5-HT4 receptor and Alzheimer's disease:: The amyloid connection

被引：57
|
作者：
Lezoualc'h, Frank [1 ]
机构：
[1] INSERM U769, F-92296 Chatenay Malabry, France
[2] Univ Paris Sud, IFR 141, Fac Pharm, F-92296 Chatenay Malabry, France
来源：
EXPERIMENTAL NEUROLOGY | 2007年 / 205卷 / 02期
关键词：
D O I：
10.1016/j.expneurol.2007.02.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：325 / 329
页数：5
相关论文
共 50 条
  • [1] Discovery of 5-HT4 receptor partial agonist for the treatment of Alzheimer's disease
    Shinde, Anil
    Kambhampati, Ramasastry
    Rasheed, Mohammed Abdul
    Dwarampudi, Adireddy
    Kota, Laxman
    Gampa, Muralimohan
    Kodru, Padmavathi
    Tiriveedhi, Vinaykumar
    Saraf, Sangram Keshri
    Subramanian, Ramkumar
    Chillakur, Muddukrishna
    Jayarajan, Pradeep
    Bhyrapuneni, Gopinadh
    Nirogi, Ramakrishna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [2] The first human in vivo study of 5-HT4 receptor binding in Alzheimer's disease
    Madsen, K.
    Marner, L.
    Neumann, W-J
    Lehel, S.
    Baare, W.
    Knudsen, G. M.
    Hasselbalch, S. G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 265 - 265
  • [3] Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment
    Lalut, Julien
    Karila, Delphine
    Dallemagne, Patrick
    Rochais, Christophe
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (08) : 781 - 795
  • [4] The serotonin 5-HT4 receptor and the amyloid precursor protein processing
    Lezoualc'h, F
    Robert, SJ
    EXPERIMENTAL GERONTOLOGY, 2003, 38 (1-2) : 159 - 166
  • [5] Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease
    Spencer, JP
    Brown, JT
    Richardson, JC
    Medhurst, AD
    Sehmi, SS
    Calver, AR
    Randall, AD
    NEUROSCIENCE, 2004, 129 (01) : 49 - 54
  • [6] Design and synthesis of newer amide derivatives as 5-HT4 receptor ligands for the treatment of Alzheimer's disease
    Shinde, Anil
    Dwarampudi, Adireddy
    Gampa, Muralimohan
    Kota, Laxman
    Kodru, Padmavathi
    Tiriveedhi, Vinaykumar
    Saraf, Sangram K.
    Gangadasari, Pamuleti Narasimhareddy
    Mohammed, Abdul Rasheed
    Subramanian, Ramkumar
    Chillakur, Muddukrishna
    Mekala, Venkatreddy
    Jayarajan, Pradeep
    Bhyrapuneni, Gopinadh
    Kandikere, Vishwottam
    Nirogi, Ramakrishna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [7] 5-HT4 AGONISTS: NOVEL PROMISING AGENTS FOR PREVENTION OF ALZHEIMER'S DISEASE
    Claeysen, S.
    Giannoni, P.
    Gaven, F.
    De Bundel, D.
    Baranger, K.
    Marchetti-Gauthier, E.
    Roman, F.
    Valjent, E.
    Marin, P.
    Bockaert, J.
    Rivera, S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 173 - 174
  • [8] 5-HT4 receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (07) : 305 - 306
  • [9] THE PHARMACOLOGY OF THE 5-HT4 RECEPTOR
    COSTALL, B
    NAYLOR, RJ
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 8 : 11 - 18
  • [10] Design, Synthesis, and Biological Evaluation of New 5-HT4 Receptor Agonists: Application as Amyloid Cascade Modulators and Potential Therapeutic Utility in Alzheimer's Disease
    Russo, Olivier
    Cachard-Chastel, Marthe
    Riviere, Celine
    Giner, Mireille
    Soulier, Jean-Louis
    Berthouze, Magali
    Richard, Tristan
    Monti, Jean-Pierre
    Sicsic, Sames
    Lezoualc'h, Frank
    Berque-Bestel, Isabelle
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2214 - 2225
12345